Esther Rajavelu

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Maegan Deare, Attorney-in-Fact for Esther Rajavelu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Esther Rajavelu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Chief Executive Officer, Chief Financial Officer and Chief Business Officer Common Stock 1,012,091 $2,388,534 $2.36 06 Feb 2026 Direct
Spero Therapeutics, Inc. Chief Executive Officer, Chief Financial Officer and Chief Business Officer Stock Option (Right to Buy) 498,000 02 Feb 2026 Direct
Fulcrum Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 160,000 09 Feb 2023 Direct

Insider Reports Filed by Esther Rajavelu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRO Spero Therapeutics, Inc. 06 Feb 2026 2 -$207,484 4 Chief Executive Officer, Chief Financial Officer and Chief Business Officer 09 Feb 2026, 21:31
SPRO Spero Therapeutics, Inc. 02 Feb 2026 3 -$40,572 4 Chief Executive Officer, Chief Financial Officer and Chief Business Officer 04 Feb 2026, 21:44
SPRO Spero Therapeutics, Inc. 07 Nov 2025 1 -$95,440 4 Chief Executive Officer, Chief Financial Officer and Chief Business Officer 12 Nov 2025, 20:44
SPRO Spero Therapeutics, Inc. 02 May 2025 1 $0 4 Chief Executive Officer, Chief Financial Officer and Chief Business Officer 06 May 2025, 20:01
SPRO Spero Therapeutics, Inc. 03 Feb 2025 3 -$16,137 4 CFO & CBO 05 Feb 2025, 20:52
SPRO Spero Therapeutics, Inc. 07 Nov 2024 2 -$53,008 4 CFO & CBO 12 Nov 2024, 16:05
SPRO Spero Therapeutics, Inc. 01 Feb 2024 1 $0 4 Chief Financial Officer and Chief Business Officer 05 Feb 2024, 20:44
SPRO Spero Therapeutics, Inc. 13 Nov 2023 1 $0 4 Chief Financial Officer and Chief Business Officer 15 Nov 2023, 16:17
SPRO Spero Therapeutics, Inc. 06 Nov 2023 0 $0 3 Chief Financial Officer and Chief Business Officer Exhibit 24.1 - Power of Attorney 15 Nov 2023, 16:15
FULC Fulcrum Therapeutics, Inc. 09 Feb 2023 1 $0 4 Chief Financial Officer 13 Feb 2023, 15:15
FULC Fulcrum Therapeutics, Inc. 03 Jan 2022 1 $0 4 Chief Financial Officer 10 Jan 2022, 15:30
FULC Fulcrum Therapeutics, Inc. 03 Jan 2022 0 $0 3 Chief Financial Officer 10 Jan 2022, 15:16